<p>Vincenzo Casolaro of the University of Maryland School of Medicine in the United States will test the ability of a novel synthetic peptide, AT1002, to induce the pathways within the mucosa to increase the delivery of antigens. If successful, this peptide could be used as an adjuvant to increase vaccine effectiveness and lower the costs of delivering vaccines.</p>


Vincenzo Casolaro of the University of Maryland School of Medicine in the United States will test the ability of a novel synthetic peptide, AT1002, to induce the pathways within the mucosa to increase the delivery of antigens. If successful, this peptide could be used as an adjuvant to increase vaccine effectiveness and lower the costs of delivering vaccines.

Fine-Tuning Mucosal Barrier Function for Vaccine Delivery

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.